Patent · US Active

Amylin derivatives

US8895504B2 · kind B2 · utility

5Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2009
Grant dateNov 25, 2014
Priority date—
Expiry dateNov 16, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Amylin derivatives, pharmaceutical compositions containing such derivatives, as well as methods of treating diabetes and hyperglycaemia are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.